Conferences
ESMO 2023: Dose Intensification and Field Expansion of External Beam Radiation Therapy
October 23, 2023
ESMO 2023: Tolerance and Long-Term Side-Effects
October 23, 2023
ESMO 2023: Usefulness and Limitations of PSMA Imaging/PET in High-Risk Localized Disease
October 23, 2023
ESMO 2023: Application of Novel Machine Learning Model in 68Ga-PSMA-11 PET/CT – Predicting Survival in Oligometastatic Prostate Cancer Patients
October 23, 2023
ESMO 2023: APEX-01: First-in-Human Phase 1/2 Study of ARX517, an Anti-PSMA ADC, in Patients with mCRPC
October 23, 2023
ESMO 2023: How to Best Integrate Biology
October 23, 2023
ESMO 2023: PSMAfore Discussant: Using Clinical Intelligence to Define First Line mCRPC Therapy
October 23, 2023
ESMO 2023: Next Generation Imaging: How Does It Change the Evidence Seen in Trials?
October 23, 2023
ESMO 2023: PSMAfore Phase 3 Trial of [177Lu]Lu-PSMA-617 in Taxane-Naive Patients with Metastatic Castration Resistant Prostate Cancer
October 23, 2023
ESMO 2023: Advances in the Molecular Understanding of GU Cancers: The Next Generation of Therapeutic Targets
October 23, 2023